Showing results (51-60 of 172) with videos related to
Sort By:
Pageof 18
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 19, 2023
Parent-reported health-related quality of life in pediatric childhood cancer survivors and factors associated with poor health-related quality of life in aftercareJana Winzig, Laura Inhestern, Verena Paul, et al.Journal of Hematology & Oncology|August 3, 2012
The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cellsChristina Halsey, Marie Docherty, Mhairi McNeill, et al.British Journal of Haematology|April 19, 2013
Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndromeFranziska Meyr, Gabriele Escherich, Georg Mann, et al.Cancer Chemotherapy and Pharmacology|September 24, 2016
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patientsVictoria J Forster, Frederik W van Delft, Susan F Baird, et al.British Journal of Haematology|June 26, 2024
Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group StudyStavroula Anastasopoulou, Gemma Swann, Liv Andres-Jensen, et al.European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96Cornelia Eckert, Arend von Stackelberg, Karl Seeger, et al.European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 5, 2013
Denosumab: a potential new and innovative treatment option for aneurysmal bone cystsTobias Lange, Christoph Stehling, Birgit Fröhlich, et al.American Journal of Blood Research|May 16, 2013
Refinement of IKZF1 recombination hotspots in pediatric BCP-ALL patientsClaus Meyer, Udo Zur Stadt, Gabriele Escherich, et al.Haematologica|August 11, 2018
Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study groupNaghmeh Niktoreh, Beate Lerius, Martin Zimmermann, et al.Blood|February 12, 2013
Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescenceBettina R Bonn, Marius Rohde, Martin Zimmermann, et al.Pageof 18